Joseph Clay Thornton - 16 May 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: Interim CFO
Issuer ticker: CLOV
Reported as of: 16 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 May 2026, 16:23:04 UTC
Prior SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Peter J. Rivas as attorney-in-fact for Joseph Clay Thornton

Key filing fact

Joseph Clay Thornton filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 18 May 2026.

Key facts

This page summarizes Joseph Clay Thornton's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 May 2026, 16:23.

Change

Previous filing in this sequence was filed on 16 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002128794 Primary reporting owner

THORNTON JOSEPH CLAY

Relationship: Interim CFO
Address: C/O CLOVER HEALTH INVESTMENTS, CORP., WILMINGTON
Signature: /s/ Peter J. Rivas as attorney-in-fact for Joseph Clay Thornton
Signature date: 18 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Tax liability

Transaction value
Shares: -16,942
Change %: -1.4%
Price: $3.47^*
Shares after: 1,217,584
Date: 16 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date.